Aytu BioPharma ($AYTU) Insider Trading & Smart Money Activity

Aytu BioPharma, Inc. · Drug Manufacturers - Specialty & Generic · Latest filing Jun 11, 2026

Aytu BioPharma, Inc. ($AYTU) has 2 analyst ratings on file.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

0

Net insider $ (12 mo)

$0

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

2

AYTU insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All AYTU insider, congress, 13F and analyst activity

All Analysts

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Jun 11, 2026	Analyst	Ascendiant Capital	Reiterates to buy		PT $14.50		+5.5%	-0.5%			Read
Jun 11, 2026	Analyst	Ascendiant Capital	Reiterates to buy		PT $14.50		+5.5%	-0.5%			Read

1W / 1M / 6M = how AYTU moved from the trade or filing date.

Analyst ratings on AYTU

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Jun 11, 2026	Ascendiant Capital	Reiterates	buy	$14.50	+5.5%	-0.5%		Read
Jun 11, 2026	Ascendiant Capital	Reiterates	buy	$14.50	+5.5%	-0.5%		Read

Other drug manufacturers - specialty & generic stocks

• $INM
• $SCYX
• $TLPH
• $ASRT
• $LFCR
• $DERM
• $ACB
• $AKBA

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.